Post Doc

Research Group Home Page: 
Miller Group

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.

E-pub date: 31 Jul 2018


CHK2 sets the stage for CK1 in oocyte quality control.

E-pub date: 01 Jun 2018


Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63.

E-pub date: 01 Mar 2018


Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome.

E-pub date: 31 Dec 2017


Control mechanisms in germ cells mediated by p53 family proteins.

E-pub date: 31 Jul 2017


Apoptosis inhibitor 5 is an endogenous inhibitor of caspase-2.

E-pub date: 01 May 2017


Structural Evolution and Dynamics of the p53 Proteins.

E-pub date: 31 Mar 2017


Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

E-pub date: 01 Dec 2016


Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level.

E-pub date: 29 Feb 2016


Functional interplay between MDM2, p63/p73 and mutant p53.

E-pub date: 31 Jul 2015


Analysis of the oligomeric state and transactivation potential of TAp73α.

E-pub date: 31 Aug 2013


The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential.

E-pub date: 01 Sep 2012


Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.

E-pub date: 31 Aug 2012


Show all